Jia‐Yong Su

机构：Guangxi Medical University · ORCID：0000-0002-0960-5394

发表论文 28 篇 · 总被引 122 次 · h-index 7

代表论文

• Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy (2025 · Hepatology · 被引 15)
• Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study (2024 · Liver Cancer · 被引 14)
• Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions (2024 · Journal of Clinical and Translational Hepatology · 被引 14)
• Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004) (2025 · JHEP Reports · 被引 7)
• Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study (2025 · Hepatology Research · 被引 7)
• miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2 (2023 · Clinical & Translational Oncology · 被引 5)